Received a "Study May Proceed” letter from the FDA to evaluate amezalpat in combination with atezolizumab (TECENTRIQ®) and ...

As companies continue to adopt AI technology and tools, developing employees' AI capabilities should be a key priority.

While focusing on building and maintaining effective teams is an activity that successful leaders are constantly focused on, ...

CCI staff share recent surveys, reports and analysis on risk, compliance, governance, infosec and leadership issues. Share ...